European Companies Search Engine
State Aid (€744,654): Walloon Decree on Innovation Sat2 Dec 2022 State Aid Transparency (Direct grant/ Interest rate subsidy)
Overview
Text
| Country | Belgium |
| Language | French |
| Aid Measure Title | Décret wallon sur l'innovation (en: Walloon Decree on Innovation) |
| SA.Number | SA.52328 |
| Ref-no. | TM-11769482 |
| National ID | 0403096168 |
| Beneficiary National ID Type | KBO/BCE |
| Name of the beneficiary | UCB PHARMA |
| Beneficiary Type | Only large enterprises |
| Region | Région wallonne |
| Sector (NACE) | Wholesale of pharmaceutical goods |
| Aid Instrument | Direct grant/ Interest rate subsidy |
| Objectives of the Aid | Experimental development (Art. 25(2)(c)) |
| Date of Granting | 02/12/2022 |
| Aid element, expressed as full amount | 744,654.00 EUR |
| Granting Authority Name | SPW DGO Economie, Emploi et Recherche (en: SPW DGO Economie, Emploi et Research) |
| Co-finance | ✓ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: UCB Pharma N.V., Anderlecht, Belgium.
The visualizations for "UCB Pharma - State Aid (€744,654): Walloon Decree on Innovation"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
